BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10878006)

  • 21. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding.
    Harris TE; Albrecht JH; Nakanishi M; Darlington GJ
    J Biol Chem; 2001 Aug; 276(31):29200-9. PubMed ID: 11369759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells.
    Jin YH; Yoo KJ; Lee YH; Lee SK
    J Biol Chem; 2000 Sep; 275(39):30256-63. PubMed ID: 10884382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
    Luo Y; Hurwitz J; Massagué J
    Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
    Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
    J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.
    Levkau B; Koyama H; Raines EW; Clurman BE; Herren B; Orth K; Roberts JM; Ross R
    Mol Cell; 1998 Mar; 1(4):553-63. PubMed ID: 9660939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.
    Smith E; Redman RA; Logg CR; Coetzee GA; Kasahara N; Frenkel B
    J Biol Chem; 2000 Jun; 275(26):19992-20001. PubMed ID: 10867026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of human thymidine kinase 1 with p21(Waf1).
    Huang DY; Chang ZF
    Biochem J; 2001 Jun; 356(Pt 3):829-34. PubMed ID: 11389691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
    Funk JO; Waga S; Harry JB; Espling E; Stillman B; Galloway DA
    Genes Dev; 1997 Aug; 11(16):2090-100. PubMed ID: 9284048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Harper JW; Adami GR; Wei N; Keyomarsi K; Elledge SJ
    Cell; 1993 Nov; 75(4):805-16. PubMed ID: 8242751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation.
    Koundrioukoff S; Jónsson ZO; Hasan S; de Jong RN; van der Vliet PC; Hottiger MO; Hübscher U
    J Biol Chem; 2000 Jul; 275(30):22882-7. PubMed ID: 10930425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
    Jones DL; Alani RM; Münger K
    Genes Dev; 1997 Aug; 11(16):2101-11. PubMed ID: 9284049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.